26672068a1e1da236c914cea5f5b3773c376de4132c56031233e5b5fb4783311

Cash and cash equivalents (USD, thousands)

Short-term investments (USD, thousands)

Restricted cash (USD, thousands)

Trade receivables, net (USD, thousands)

Receivables and prepaid expenses (USD, thousands)

Inventories (USD, thousands)

Total current assets (USD, thousands)

Property and equipment, net (USD, thousands)

Field equipment, net (USD, thousands)

Right-of-use assets (USD, thousands)

Other long-term assets (USD, thousands)

Total long-term assets (USD, thousands)

TOTAL ASSETS (USD, thousands)

Convertible note, current (USD, thousands)

Trade payables (USD, thousands)

Other payables, lease liabilities and accrued expenses (USD, thousands)

Total current liabilities (USD, thousands)

Convertible note, long-term (USD, thousands)

Senior secured credit facility, net (USD, thousands)

Long-term leases (USD, thousands)

Employee benefit liabilities (USD, thousands)

Other long-term liabilities (USD, thousands)

Total long-term liabilities (USD, thousands)

TOTAL LIABILITIES (USD, thousands)

Additional paid-in capital (USD, thousands)

Accumulated other comprehensive income (loss) (USD, thousands)

Retained earnings (accumulated deficit) (USD, thousands)

TOTAL SHAREHOLDERS' EQUITY (USD, thousands)

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (USD, thousands)

5fdde76c3ff3141fbec8d43ccd2346513392dd41f266705fefe370e727bc67be

Net revenues (USD, thousands)

Cost of revenues (USD, thousands)

Gross profit (USD, thousands)

Research, development and clinical studies (USD, thousands)

Sales and marketing (USD, thousands)

General and administrative (USD, thousands)

Total operating costs and expenses (USD, thousands)

Operating income (loss) (USD, thousands)

Financial income (expenses), net (USD, thousands)

Income (loss) before income tax (USD, thousands)

Income tax (USD, thousands)

Net income (loss) (USD, thousands)

Basic and diluted net income (loss) per ordinary share (USD per share)

Weighted average number of ordinary shares used in computing basic and diluted net income (loss) per share (shares)

13e6c68215fe9481f3a36176a8cacf0953aa71177861f4cf1c083bb521eaba70

Depreciation and amortization (USD, thousands)

Asset write-downs and impairment of field equipment (USD, thousands)

Share-based compensation (USD, thousands)

Foreign currency remeasurement loss (gain) (USD, thousands)

Decrease (increase) in accounts receivables and prepaid expenses (USD, thousands)

Amortization of discount (premium) (USD, thousands)

Decrease (increase) in inventories (USD, thousands)

Decrease (increase) in other long-term assets (USD, thousands)

Increase (decrease) in accounts payables and accrued expenses (USD, thousands)

Increase (decrease) in other long-term liabilities (USD, thousands)

Net cash provided by (used in) operating activities (USD, thousands)

Purchase of property, equipment and field equipment (USD, thousands)

Proceeds from maturity of short-term investments (USD, thousands)

Purchase of short-term investments (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Proceeds from issuance of shares, net (USD, thousands)

Proceeds from senior secured credit facility, net (USD, thousands)

Repayment and redemption of long-term debt (USD, thousands)

Exercise of options (USD, thousands)

Net cash provided by (used in) financing activities (USD, thousands)

Effect of exchange rate changes on cash, cash equivalents and restricted cash (USD, thousands)

Increase (decrease) in cash, cash equivalents and restricted cash (USD, thousands)

Income taxes paid (refunded), net (USD, thousands)

Interest paid (USD, thousands)

Right-of-use assets obtained (disposed) in exchange for lease liabilities (USD, thousands)

Accrued Interest (USD, thousands)

Cash, cash equivalents and restricted cash at the beginning of the period (USD, thousands)

Cash, cash equivalents and restricted cash at the end of the period (USD, thousands)

NovoCure (NVCR)

Financials